Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 1,690.43 | 1,417.53 | 1,546.83 | 1,188.06 |
Total Revenue | 1,690.43 | 1,417.53 | 1,546.83 | 1,188.06 |
Costof Revenue Total | 1,062.42 | 970.37 | 1,060.94 | 786.78 |
Gross Profit | 628.01 | 447.16 | 485.89 | 401.28 |
Selling/ General/ Admin Expenses Total | 347.39 | 293.70 | 271.95 | 225.24 |
Depreciation/ Amortization | 33.47 | 27.93 | 27.64 | 30.28 |
Other Operating Expenses Total | 121.99 | 70.86 | 74.26 | 51.88 |
Total Operating Expense | 1,565.28 | 1,365.93 | 1,437.80 | 1,099.83 |
Operating Income | 125.16 | 51.60 | 109.03 | 88.23 |
Interest Inc( Exp) Net- Non- Op Total | -37.10 | -3.23 | 86.95 | 3.46 |
Other Net | 13.97 | 4.48 | 8.98 | 9.93 |
Net Income Before Taxes | 135.42 | 55.76 | 126.70 | 98.51 |
Provisionfor Income Taxes | 38.80 | 17.08 | 25.02 | 1.42 |
Net Income After Taxes | 96.62 | 38.68 | 101.68 | 97.09 |
Minority Interest | -0.46 | 0.00 | 0.00 | 0.00 |
Net Income Before Extra Items | 96.16 | 38.68 | 101.68 | 97.09 |
Net Income | 96.16 | 38.68 | 101.68 | 97.09 |
Income Availableto Com Excl Extra Ord | 96.16 | 38.68 | 101.68 | 97.09 |
Income Availableto Com Incl Extra Ord | 96.16 | 38.68 | 101.68 | 97.09 |
Diluted Net Income | 96.16 | 38.68 | 101.68 | 97.09 |
Diluted Weighted Average Shares | 51.15 | 50.22 | 51.98 | 45.11 |
Diluted EPS Excluding Extra Ord Items | 1.88 | 0.77 | 1.96 | 2.15 |
Diluted Normalized EPS | 1.88 | 0.77 | 1.96 | 2.15 |
Research Development | - | 30.69 | 30.08 | 56.46 |
Morepen Laboratories Dividend Morepen Laboratories Bonus Morepen Laboratories News Morepen Laboratories AGM Morepen Laboratories Rights Morepen Laboratories Splits Morepen Laboratories Board Meetings Morepen Laboratories Key Metrics Morepen Laboratories Shareholdings Morepen Laboratories Balance Sheet Morepen Laboratories Cashflow Morepen Laboratories Q1 Results Morepen Laboratories Q2 Results Morepen Laboratories Q3 Results Morepen Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks